Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.
587 questions in 116 reviews · Eyes and Vision
current versionsNo studies 587 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Summary of findings: intracanalicular vs silicone punctal plugs Adverse events · adults with dry eye syndrome Punctal occlusion for dry eye syndrome (2017) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings: autologous serum vs saline Fluorescein staining Range of scale: 0‐9, where a higher score is worse · participants with dry eye Autologous serum eye drops for dry eye (2017) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings: autologous serum vs saline Tear film break‐up time · participants with dry eye Autologous serum eye drops for dry eye (2017) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings: autologous serum vs saline Schirmer’s test Score < 4 mm indicates severe dry eye · participants with dry eye Autologous serum eye drops for dry eye (2017) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings: autologous serum vs saline Adverse events · participants with dry eye Autologous serum eye drops for dry eye (2017) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings: autologous serum vs artificial tears Tear hyperosmolarity · participants with dry eye Autologous serum eye drops for dry eye (2017) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings: autologous serum vs artificial tears Adverse events · participants with dry eye Autologous serum eye drops for dry eye (2017) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings: autologous serum vs saline Participant‐reported symptoms · participants with dry eye Autologous serum eye drops for dry eye (2017) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings: autologous serum vs saline Tear hyperosmolarity · participants with dry eye Autologous serum eye drops for dry eye (2017) · Cochrane | no estimate extracted | NR | No studies |
Topical NSAIDs vs control Participant‐reported pain intensity reduction of 30%/50% or greater at 24 hours · analgesia in traumatic corneal abrasions Topical non‐steroidal anti‐inflammatory drugs for analgesia in traumatic corneal abrasions (2017) · Cochrane | no estimate extracted | NR | No studies |
Topical NSAIDs vs control Use of rescue oral analgesia at 48/72 hours · analgesia in traumatic corneal abrasions Topical non‐steroidal anti‐inflammatory drugs for analgesia in traumatic corneal abrasions (2017) · Cochrane | no estimate extracted | NR | No studies |
Smaller coaxial microincision cataract surgery (C‐MICS) vs standard phacoemulsification Adverse events · adults with age‐related cataract Different‐sized incisions for phacoemulsification in age‐related cataract (2017) · Cochrane | no estimate extracted | NR | No studies |
Smaller coaxial microincision cataract surgery (C‐MICS) vs standard phacoemulsification Quality of life · adults with age‐related cataract Different‐sized incisions for phacoemulsification in age‐related cataract (2017) · Cochrane | no estimate extracted | NR | No studies |
Smaller coaxial microincision cataract surgery (C‐MICS) vs larger C‐MICS Adverse events · adults with age‐related cataract Different‐sized incisions for phacoemulsification in age‐related cataract (2017) · Cochrane | no estimate extracted | NR | No studies |
Smaller coaxial microincision cataract surgery (C‐MICS) vs larger C‐MICS Quality of life · adults with age‐related cataract Different‐sized incisions for phacoemulsification in age‐related cataract (2017) · Cochrane | no estimate extracted | NR | No studies |
Biaxial microincision cataract surgery (B‐MICS) vs standard phacoemulsification Adverse events · adults with age‐related cataract Different‐sized incisions for phacoemulsification in age‐related cataract (2017) · Cochrane | no estimate extracted | NR | No studies |
Biaxial microincision cataract surgery (B‐MICS) vs standard phacoemulsification Quality of life · adults with age‐related cataract Different‐sized incisions for phacoemulsification in age‐related cataract (2017) · Cochrane | no estimate extracted | NR | No studies |
Larger coaxial microincision cataract surgery (C‐MICS) vs standard phacoemulsification Quality of life · adults with age‐related cataract Different‐sized incisions for phacoemulsification in age‐related cataract (2017) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings for NSAIDs plus corticosteroids vs corticosteroids alone Proportion of participants with best‐corrected visual acuity of 20/40 1 week · people who received phacoemulsification Non‐steroidal anti‐inflammatory drugs versus corticosteroids for controlling inflammation after… (2017) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings for NSAIDs plus corticosteroids vs corticosteroids alone Time to cessation of treatment · people who received phacoemulsification Non‐steroidal anti‐inflammatory drugs versus corticosteroids for controlling inflammation after… (2017) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings for NSAIDs plus corticosteroids vs corticosteroids alone Adverse events · people who received phacoemulsification Non‐steroidal anti‐inflammatory drugs versus corticosteroids for controlling inflammation after… (2017) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings for NSAIDs plus corticosteroids vs corticosteroids alone Economic outcomes · people who received phacoemulsification Non‐steroidal anti‐inflammatory drugs versus corticosteroids for controlling inflammation after… (2017) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings for NSAIDs vs corticosteroids Proportion of participants with best‐corrected visual acuity of 20/40 1 week · people who received phacoemulsification Non‐steroidal anti‐inflammatory drugs versus corticosteroids for controlling inflammation after… (2017) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings for NSAIDs vs corticosteroids Time to cessation of treatment · people who received phacoemulsification Non‐steroidal anti‐inflammatory drugs versus corticosteroids for controlling inflammation after… (2017) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings for NSAIDs vs corticosteroids Adverse events · people who received phacoemulsification Non‐steroidal anti‐inflammatory drugs versus corticosteroids for controlling inflammation after… (2017) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings for NSAIDs vs corticosteroids Economic outcomes · people who received phacoemulsification Non‐steroidal anti‐inflammatory drugs versus corticosteroids for controlling inflammation after… (2017) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings for NSAIDs plus corticosteroids vs corticosteroids alone Intraocular inflammation measured by anterior chamber cell and flare 1 week · people who received phacoemulsification Non‐steroidal anti‐inflammatory drugs versus corticosteroids for controlling inflammation after… (2017) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Proportion of participants with IOP < 21 mmHg at 1 year' · participants with glaucoma or ocular hypertension Topical medication instillation techniques for glaucoma (2017) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Mean IOP change from baseline at 1 year' · participants with glaucoma or ocular hypertension Topical medication instillation techniques for glaucoma (2017) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Participant‐reported outcomes related to the ease, convenience, and comfort of instillation at 1 year' · participants with glaucoma or ocular hypertension Topical medication instillation techniques for glaucoma (2017) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Physiologic measurements of systemic absorption at 1 year' · participants with glaucoma or ocular hypertension Topical medication instillation techniques for glaucoma (2017) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Escalation of therapy at 1 year' · participants with glaucoma or ocular hypertension Topical medication instillation techniques for glaucoma (2017) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Mean change in visual fields at 1 year' · participants with glaucoma or ocular hypertension Topical medication instillation techniques for glaucoma (2017) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Adverse events at 1 year' · participants with glaucoma or ocular hypertension Topical medication instillation techniques for glaucoma (2017) · Cochrane | no estimate extracted | NR | No studies |
Brimonidine vs apraclonidine IOP increase of ≥ 5 mmHg between 2 and 24 hours · people with glaucoma receiving LTP Perioperative medications for preventing temporarily increased intraocular pressure after laser… (2017) · Cochrane | no estimate extracted | NR | No studies |
Brimonidine vs apraclonidine IOP increase of ≥ 10 mmHg between 2 and 24 hours · people with glaucoma receiving LTP Perioperative medications for preventing temporarily increased intraocular pressure after laser… (2017) · Cochrane | no estimate extracted | NR | No studies |
Brimonidine vs apraclonidine Mean change in IOP from pre‐LTP between 2 and 24 hours · people with glaucoma receiving LTP Perioperative medications for preventing temporarily increased intraocular pressure after laser… (2017) · Cochrane | no estimate extracted | NR | No studies |
Brimonidine vs apraclonidine Adverse events ‐ during study period · people with glaucoma receiving LTP Perioperative medications for preventing temporarily increased intraocular pressure after laser… (2017) · Cochrane | no estimate extracted | NR | No studies |
Apraclonidine vs pilocarpine IOP increase of ≥ 5 mmHg within 2 hours · people with glaucoma receiving LTP Perioperative medications for preventing temporarily increased intraocular pressure after laser… (2017) · Cochrane | no estimate extracted | NR | No studies |
Apraclonidine vs pilocarpine IOP increase of ≥ 10 mmHg within 2 hours · people with glaucoma receiving LTP Perioperative medications for preventing temporarily increased intraocular pressure after laser… (2017) · Cochrane | no estimate extracted | NR | No studies |
Apraclonidine vs pilocarpine Adverse events ‐ during study period · people with glaucoma receiving LTP Perioperative medications for preventing temporarily increased intraocular pressure after laser… (2017) · Cochrane | no estimate extracted | NR | No studies |
Medication given before LTP vs the same medication given after LTP IOP increase of ≥ 5 mmHg within 2 hours · people with glaucoma receiving LTP Perioperative medications for preventing temporarily increased intraocular pressure after laser… (2017) · Cochrane | no estimate extracted | NR | No studies |
Medication given before LTP vs the same medication given after LTP IOP increase of ≥ 10 mmHg within 2 hours · people with glaucoma receiving LTP Perioperative medications for preventing temporarily increased intraocular pressure after laser… (2017) · Cochrane | no estimate extracted | NR | No studies |
Medication given before LTP vs the same medication given after LTP Mean change in IOP from pre‐LTP within 2 hours · people with glaucoma receiving LTP Perioperative medications for preventing temporarily increased intraocular pressure after laser… (2017) · Cochrane | no estimate extracted | NR | No studies |
Medication given before LTP vs the same medication given after LTP Adverse events ‐ during study period · people with glaucoma receiving LTP Perioperative medications for preventing temporarily increased intraocular pressure after laser… (2017) · Cochrane | no estimate extracted | NR | No studies |
Brimonidine vs apraclonidine IOP increase of ≥ 10 mmHg within 2 hours · people with glaucoma receiving LTP Perioperative medications for preventing temporarily increased intraocular pressure after laser… (2017) · Cochrane | no estimate extracted | NR | No studies |
Acupuncture vs topical antibiotics plus warm compresses Participants who required surgical incision and drainage after the treatment period or seven days after diagnosis · people with acute hordeolum Acupuncture for acute hordeolum (2017) · Cochrane | no estimate extracted | NR | No studies |
Acupuncture vs topical antibiotics plus warm compresses Participants experiencing the occurrence of a chalazion after the treatment period or seven days after diagnosis · people with acute hordeolum Acupuncture for acute hordeolum (2017) · Cochrane | no estimate extracted | NR | No studies |
Acupuncture vs topical antibiotics plus warm compresses Participants experiencing the recurrence of a hordeolum within six months and one year · people with acute hordeolum Acupuncture for acute hordeolum (2017) · Cochrane | no estimate extracted | NR | No studies |
Acupuncture vs topical antibiotics plus warm compresses Participants with a secondary hordeolum during or after the treatment period and seven days after diagnosis · people with acute hordeolum Acupuncture for acute hordeolum (2017) · Cochrane | no estimate extracted | NR | No studies |